Stan Rose has been named to the board of directors at Nabsys, a Providence, RI-based startup developing an electronic, solid-state DNA sequencing platform.
Rose is president of Rose Ventures, which provides life sciences consulting and manages a portfolio of public and private equity investments. He served previously as CEO of NimbleGen Systems, until it was acquired by Roche in 2007.
Rose also co-founded Genetic Microsystems, which was acquired by Affymetrix in 2000. Prior to that, Rose led the PCR business for Perkin-Elmer and Applied Biosystems.
CombiMatrix has named Chris Emery and Lony Lim to serve as chief operations officer and vice president of operations, respectively, of its CombiMatrix Molecular Diagnostics subsidiary.
Emery previously was a marketing manager with US Labs, a division of Laboratory Corporation of America, and he was VP of sales and marketing at Response Genetics. Lim was director of scientific affairs, flow cytometry, and anatomic pathology at US Labs and scientific director of the division of immunology at Ameripath Specialty Laboratories, and he helped pioneer Luminex's xMAP technology, said CombiMatrix.